PMC:7079563 / 24396-24605 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    ents with 2019-nCoV disease [45]. Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human prim

    LitCovid-PD-FMA-UBERON

    ents with 2019-nCoV disease [45]. Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human prim

    LitCovid-PD-MONDO

    ents with 2019-nCoV disease [45]. Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human prim

    LitCovid-PD-CLO

    ents with 2019-nCoV disease [45]. Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human prim

    LitCovid-PD-CHEBI

    ents with 2019-nCoV disease [45]. Remdesivir has recently been recognized as a promising antiviral drug against multiple RNA viruses (including SARS/MERS-CoV) in cultured cells, and in mouse and non-human prim